A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/Ribociclib
Clinical trial NCT03050398 · TERMINATED
Trial details
- NCT number
- NCT03050398
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-07
- Primary completion
- 2019-03-08
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.